The perils of not digging deep enough-uncovering a rare cause of acquired anemia

American Journal of Hematology

Volumn 87, Issue 4, 2012, Pages 413-416

  Saini, Neeraj ^a   Jacobson, Joseph O ^b   Jha, Smita ^a   Saini, Vivek ^c   Weinger, Ronald ^d  

^a Dana Farber Cancer Institute ^*

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Pravara Institute of Medical Sciences   (India)

^d Boston MA 02114 USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ERYTHROPOIETIN; HEMOGLOBIN; IRON; LINEZOLID;

AGED; AORTA VALVE STENOSIS; ARTICLE; BODY MASS; BONE MARROW BIOPSY; CASE REPORT; CYTOPLASM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSERYTHROPOIESIS; DYSPNEA; ERYTHROBLAST; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HEMATOCRIT; HIP ARTHROPLASTY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IRON STORAGE; KNEE ARTHROPLASTY; MEAN CORPUSCULAR VOLUME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIDEROBLASTIC ANEMIA; SYSTOLIC HEART MURMUR; THROMBOCYTE COUNT;

ACETAMIDES; AGED; ANEMIA, REFRACTORY; ANEMIA, SIDEROBLASTIC; ANTI-BACTERIAL AGENTS; ARTHROPLASTY; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COMBINED MODALITY THERAPY; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; FEMALE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OBESITY, MORBID; OXAZOLIDINONES; POLYPHARMACY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; REOPERATION;

EID: 84858298410     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22235     Document Type: Article

References (20)

1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
2. Green SL, Maddox JC, Huttenbach ED. LZD and reversible myelosuppression. J Am Med Assoc 2001; 285: 1291.
3. Abena PA, Mathieux VG, Scheiff JM, et al. Linezolid and reversible myelosuppression. J Am Med Assoc 2001; 286: 1973.
4. Michele H. Linezolid-induced pancytopenia. Clin Infect Dis 2002; 35: 347-348.
5. Taketani T, Kanai R, Fukuda S, et al. Pure red cell precursor toxicity by LZD in a pediatric case. J Pediatr Hematol Oncol 2009; 31: 684-686.
6. Faguer S, Kamar N, Fillola G, et al. LZD-related pancytopenia in organ-transplant patients: Report of two cases. Infection 2007; 35: 275-277.
7. Lakhani N, Thompson W, Bombassaro AM. Probable LZD-induced pancytopenia. Can J Infect Dis Med Microbiol 2005; 16: 286-288.
8. Monson T, Schichman SA, Zent CS. LZD-induced pure red blood cell aplasia. Clin Infect Dis 2002; 35: E29-E31.
9. Dawson MA, Davis A, Elliott P, et al. LZD-induced dyserythropoiesis: Chloramphenicol toxicity revisited. Intern Med J 2005; 35: 626-628.
10. Montpetit MC, Shammo JL, Loew J, et al. Sideroblastic anemia due to LZD in a patient with a left ventricular assist device. J Heart Lung Transplant 2004; 23: 1119-1122.
11. Kakimoto T, Nakazato T, Miura R, et al. Sideroblastic anemia after prolonged linezolid therapy. Rinsho Ketsueki 2008; 49: 1566-1568.
12. Attassi K, Hershberger E, Alam R, et al. Thrombocytopenia associated with LZD therapy. Clin Infect Dis 2002; 34: 695-698.
13. Lund JE, Brown PK. Hypersegmented megakaryocytes & megakaryocytes with multiple separate nuclei in dogs treated with PNU-100592, an oxazolidinone antibiotic. Toxicol Pathol 1997; 25: 339-343.
14. Swaney SM, Aoki H, Ganoza MC, et al. The oxazolidinone LZD inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998; 42: 3251-3255.
15. Kloss P, Xiong L, Shinabarger DL, et al. Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor LZD in the ribosomal peptidyl transferase center. J Mol Biol 1999; 294: 93-101.
16. Gemmell CG, Ford CW. Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of LZD. J Antimicrob Chemother 2002; 50: 665-672.
17. Soriano A, Miró O, Mensa J. Mitochondrial toxicity associated with LZD. N Engl J Med 2005; 353: 2305-2306.
18. Wu VC, Wang YT, Wang CY. High frequency of LZD-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 2006; 42: 66-72.
19. Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
20. Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts. New Engl J Med 2011; 365: 1384-1395.